MEDIPOST Co., Ltd. (KOSDAQ:078160)

South Korea flag South Korea · Delayed Price · Currency is KRW
10,690
+320 (3.09%)
Aug 28, 2025, 3:30 PM KST
3.09%
Market Cap353.60B
Revenue (ttm)71.85B
Net Income (ttm)-72.06B
Shares Out34.10M
EPS (ttm)-2,113.41
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume58,478
Average Volume33,532
Open10,510
Previous Close10,370
Day's Range10,200 - 10,860
52-Week Range5,510 - 15,180
Beta0.50
RSI48.57
Earnings DateAug 14, 2025

About MEDIPOST

MEDIPOST Co., Ltd. engages in the cord blood bank business in South Korea and internationally. The company operates through three divisions: Cord Blood Bank, Stem Cell Therapy, and Health Functional Food. It operates cord blood bank under the CELLTREE name. The company also offers CARTISTEM for the treatment of repetitive and/or traumatic cartilage degeneration, including degenerative osteoarthritis. In addition, it is developing stem cell products, such as PNEUMOSTEM for the preventative treatment of bronchopulmonary dysplasia. Further, the co... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2000
Employees 328
Stock Exchange KOSDAQ
Ticker Symbol 078160
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.